학술논문
GS-012 - Week 48 results of the phase 3 D-LIVR study, a randomized double-blind, placebo-controlled trial evaluating the safety and efficacy of Lonafarnib-boosted with Ritonavir with or without Peginterferon Alfa in patients with chronic hepatitis delta
Document Type
Abstract
Author
Etzion, Ohad; Hamid, Saeed Sadiq; Asselah, Tarik; Gherlan, George Sebastian; Turcanu, Adela; Petrivna, Tsarynna; Weissfeld, Lisa; Choong, Ingrid; Hislop, Colin; Apelian, David; Buti, Maria; Gheorghe, Liana; Iliescu, Elena Laura; Voronkova, Natalia; Barsukova, Natalia; Aleman, Soo; Feld, Jordan J.; Reau, Nancy S; Brunetto, Maurizia; Lampertico, Pietro; Heller, Theo; Koh, Chris; Yurdaydin, Cihan; Glenn, Jeffrey
Source
In Journal of Hepatology June 2023 78 Supplement 1:S10-S10
Subject
Language
ISSN
0168-8278